Abstracteinreichung

Die Abstracteinreichung ist geschlossen

Guidelines für die Abstracteinreichung (in Englisch)

All abstracts have to be submitted in one language only (German, French, or English). All abstract presentations have to be done in English.

Each abstract requires:

• Title (please do not use capitals only, e.g. use "ERG in Glaucoma" instead of "ERG IN GLAUCOMA". Use American spelling and verify with the appropriate spell-check.)
• A maximum of 2500 characters (including spaces), including the sections Purpose, Methods, Results, and Conclusion.
• Mentioning of all authors
• Mentioning of all affiliations (corresponding company/institution, department, location, and country)

Disclosure of Financial Interests and Grants (at the end of the abstract):

• Support from a for-profit company or competing company
• Personal investment in a company or competing company (other than through a mutual or retirement fund)
• Employment by a company or competing company with business interest in the topic
• Being a consultant of a company or competing company with business interest in the topic
• Inventor/Developer of the topic or a competing topic
• Travel Reimbursement, gifts or honoraria of over $3000 in the last twelve months by a company or competing company involved
• None: No commercial relationship

By submitting the abstract, the first author certifies that

• the material submitted has not been published previously,
• investigations on human subjects have been reviewed by the local ethical committee and are in accordance with the tenets of the Declaration of Helsinki,
• animal studies comply with the "ARVO Statement for the Use of Animals in Ophthalmic and Vision Research",
• each co-author is aware of the commercial relationships policy,
• relevant commercial relationships are disclosed at the end of the abstract.

Submitted abstracts will be received by the congress secretariat. You will receive an e-mail notification confirming the reception of your abstract.

Peer review by the scientific commission will take about 8 weeks. Subsequently, you will be informed by e-mail about acceptance and type of presentation (poster or free paper).

You may withdraw your abstract by notifying the congress secretariat.

No exclusion with regard to the topics addressed is projected but studies without direct clinical relevance  have a high probability to get acceptance for posters only at the SOG-SSO Annual Congress.

If the authors indicate their desired presentation form as Free Paper or Free Paper or ePoster when submitting, they must accept a classification by the Scientific Commission as one of the possible presentation types. If the authors specify their desired presentation form as an ePoster when submitting, the abstract can only be automatically accepted as an ePoster, without oral presentation.

An author can only have one free paper or oral presentation in a plenary symposium per topic field, but multiple free papers or oral presentations in a plenary symposium for different topic fields are possible. Any additional submitted abstracts would be presented as rapid fire presentations or ePosters.

The abstract evaluated best in a topic field is selected to be presented in the relevant plenary symposium. The authors of these abstracts will be informed via e-mail.

Deadlines

SOP zu Abstractmanagement und Preisevaluationsprozesse

Eine detaillierte Beschreibung der Prozesse des Abstractmanagements und der Preisevaluationsprozesse der SOG Wissenschaftlichen Kommission finden Sie hier.

Kontakt

Falls Sie Fragen zur Abstracteinreichung haben, wenden Sie sich bitte an das Kongresssekretariat IMK: abstracts@imk.ch